Physician profile
Christopher Ellis
NPI 1568018414
$1,949.10
in general payments reported to CMS, 2019-2025
17 companies · $542 in 2025
The $542 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $135 · 2022: $307 · 2023: $300 · 2024: $666 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,507.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $321.41 | 2022-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $257.36 | 2023-2025 | Eliquis, Camzyos |
| Abiomed | $237.81 | 2024-2025 | Impella |
| Cvrx, INC. | $164.27 | 2024-2025 | Barostim Neo System |
| Amgen INC. | $157.57 | 2021-2024 | Repatha |
| Medtronic, INC. | $128.91 | 2025 | Micra, Linq II, Azure Xt Dr Mri Surescan |
| Janssen Pharmaceuticals, INC | $126.52 | 2021-2022 | |
| United Therapeutics Corporation | $114.30 | 2024 | Tyvaso |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $109.22 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $109.06 | 2021-2023 | |
| Pfizer INC. | $70.79 | 2022-2023 | |
| Novo Nordisk INC | $36.28 | 2023-2025 | Ozempic, Rybelsus |
| Kestra Medical Technology Services, INC. | $36.12 | 2025 | Assure Wcd |
| Itamar Medical INC | $32.81 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.29 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $16.83 | 2021 | |
| Alnylam Pharmaceuticals INC. | $12.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.